World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
90
Citations
36998
World Ranking
1060
National Ranking
572

Medicine

D-Index
93
Citations
38227
World Ranking
10759
National Ranking
5534

Pramod K. Srivastava publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Pramod K. Srivastava sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 321 publications — 68th percentile

68% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Pramod K. Srivastava D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Pramod K. Srivastava sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 90 D-Index — 79th percentile

79% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2015 - Fellow, National Academy of Inventors

Overview

Pramod K. Srivastava is affiliated with the University of Connecticut in the United States. Their research primarily spans the fields of Immunology and Microbiology, with a significant focus also on Medicine. Within these domains, Srivastava has concentrated on several subfields including Immunology, Molecular Biology, Oncology, Psychiatry and Mental Health, and Radiology, Nuclear Medicine and Imaging.

The main topics of Srivastava's research include Immunotherapy and Immune Responses, Immune Cell Function and Interaction, T-cell and B-cell Immunology, as well as vaccines and immunoinformatics approaches. Additional topics covered in their work are Cancer, Stress, Anesthesia, and Immune Response, Monoclonal and Polyclonal Antibodies Research, and CAR-T cell therapy research.

Srivastava has contributed to numerous publications, with frequent appearances in several key scientific venues. The following journals have featured their work multiple times:

  • The Journal of Immunology (12 publications)
  • Journal of Clinical Investigation (2 publications)
  • Current Protocols (1 publication)
  • Nature Immunology (1 publication)
  • Science Immunology (1 publication)

Some of the recent papers authored or co-authored by Srivastava include:

  • Heat-Shock Proteins, 2022, Current Protocols
  • Sympathetic nervous tone limits the development of myeloid-derived suppressor cells, 2020, Science Immunology
  • Cross-dressing of CD8α+ Dendritic Cells with Antigens from Live Mouse Tumor Cells Is a Major Mechanism of Cross-priming, 2020, Cancer Immunology Research
  • An unbiased approach to defining bona fide cancer neoepitopes that elicit immune-mediated cancer rejection, 2020, Journal of Clinical Investigation
  • Reversion analysis reveals the in vivo immunogenicity of a poorly MHC I-binding cancer neoepitope, 2021, Nature Communications

Srivastava has collaborated extensively with several frequent co-authors, among them:

  • Ion Măndoiu (14 co-authored works)
  • Adam T. Hagymasi (10 co-authored works)
  • Marmar R. Moussa (8 co-authored works)
  • Tatiana Shcheglova (6 co-authored works)
  • James Nevin (5 co-authored works)

The body of Srivastava's work reflects a broad engagement with immune system mechanisms, cancer immunology, and therapeutic approaches involving immune modulation. In 2015, Srivastava was recognized as a Fellow of the National Academy of Inventors, indicating involvement in innovative research developments.

Best Publications

  • Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study.

    Nicole M. Kuderer;Toni K. Choueiri;Dimpy P. Shah;Yu Shyr

  • Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-κB pathway

    Sreyashi Basu;Robert J. Binder;Ryuichiro Suto;Kirstin M. Anderson

  • CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin.

    Sreyashi Basu;Robert J. Binder;Thirumalai Ramalingam;Pramod K. Srivastava

  • Roles of heat-shock proteins in innate and adaptive immunity

    Pramod Srivastava

  • Interaction of Heat Shock Proteins with Peptides and Antigen Presenting Cells: Chaperoning of the Innate and Adaptive Immune Responses

    Pramod Srivastava

  • A Mechanism for the Specific Immunogenicity of Heat Shock Protein-Chaperoned Peptides

    Ryuichiro Suto;Pramod K. Srivastava

  • Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations

    Yasuaki Tamura;Ping Peng;Kang Liu;Maria Daou

  • Heat shock protein 70-associated peptides elicit specific cancer immunity.

    Heiichiro Udono;Pramod K. Srivastava

  • CD91: a receptor for heat shock protein gp96.

    Robert J. Binder;David K. Han;Pramod K. Srivastava

  • Heat Shock Protein–Peptide Complexes, Reconstituted In Vitro, Elicit Peptide-specific Cytotoxic T Lymphocyte Response and Tumor Immunity

    Nathalie E. Blachere;Zihai Li;Rajiv Y. Chandawarkar;Ryuichiro Suto

  • Heat Shock Proteins Come of Age: Primitive Functions Acquire New Roles in an Adaptive World

    Pramod K Srivastava;Antoine Menoret;Sreyashi Basu;Robert J Binder

  • Heat shock proteins transfer peptides during antigen processing and CTL priming

    Pramod K. Srivastava;Heiichiro Udono;Nathalie E. Blachere;Zihai Li

  • Tumor rejection antigens of chemically induced sarcomas of inbred mice.

    Pramod K. Srivastava;Albert B. Deleo;Lloyd J. Old

  • Classification of current anticancer immunotherapies

    Lorenzo Galluzzi;Erika Vacchelli;José Manuel Bravo-San Pedro;Aitziber Buqué

  • Comparison of tumor-specific immunogenicities of stress-induced proteins gp96, hsp90, and hsp70.

    Heiichiro Udono;Pramod K. Srivastava

  • Heat Shock Protein gp96 Is a Master Chaperone for Toll-like Receptors and Is Important in the Innate Function of Macrophages

    Yi Yang;Bei Liu;Jie Dai;Pramod K. Srivastava

  • Vaccination of Metastatic Melanoma Patients With Autologous Tumor-Derived Heat Shock Protein gp96-Peptide Complexes: Clinical and Immunologic Findings

    Filiberto Belli;Alessandro Testori;Licia Rivoltini;Michele Maio

  • Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction

    Daniel K. Wells;Marit M. van Buuren;Kristen K. Dang;Vanessa M. Hubbard-Lucey

  • Cellular requirements for tumor-specific immunity elicited by heat shock proteins: Tumor rejection antigen gp96 primes CD8+ T cells in vivo

    Heiichiro Udono;Daniel L. Levey;Pramod K. Srivastava

  • An adjuvant autologous therapeutic vaccine (HSPPC-96; vitespen) versus observation alone for patients at high risk of recurrence after nephrectomy for renal cell carcinoma: a multicentre, open-label, randomised phase III trial

    Christopher Wood;Pramod Srivastava;Ronald Bukowski;Louis Lacombe

  • Heat-shock proteins.

    Zihai Li;Pramod Srivastava

  • Tumor rejection antigens of chemically induced sarcomas of inbred mice (cell surface antigens/M, 96,000 glycoprotein/tumor-enhancing activity)

    Pramod K. Srivastava;Albert B. Deleo;Lloyd J. Old

Frequent Co-Authors

Zihai Li
Zihai Li The Ohio State University
Giorgio Parmiani
Giorgio Parmiani University of Siena
Licia Rivoltini
Licia Rivoltini Fondazione IRCCS Istituto Nazionale dei Tumori
Lloyd J. Old
Lloyd J. Old Ludwig Cancer Research
Robert G. Maki
Robert G. Maki University of Pennsylvania
Michele Maio
Michele Maio University of Siena
Vincenzo Mazzaferro
Vincenzo Mazzaferro University of Milan
Vijay P. Singh
Vijay P. Singh Texas A&M University
Chiara Castelli
Chiara Castelli University of Milan
Christopher G. Wood
Christopher G. Wood The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA can open doors to various healthcare careers, many of which overlap with nursing and specialized clinical roles. For those interested in advancing quickly into patient-centered professions, exploring accelerated nursing programs can be a strategic choice. Students often look for accelerated nursing programs near me to swiftly transition into nursing careers after foundational studies in immunology or related fields.

Additionally, practical nursing roles are highly accessible through programs specifically designed to be straightforward and flexible. If you want to enter the healthcare workforce efficiently, searching for easy lpn programs to get into can help launch your career as a Licensed Practical Nurse, focusing on patient care that often involves immunological knowledge.

For those aiming to specialize further, nursing advancement programs like nurse practitioner degrees offer expanded clinical responsibilities and leadership opportunities. Discovering the easiest nurse practitioner degree programs can facilitate a smoother path toward advanced practice.

Mental health also intersects with immunology in understanding mind-body connections. Pursuing specialized paths such as psychiatric-mental health nurse practitioner roles is possible through well-supported educational programs. Top-rated options include top online pmhnp programs that offer strong clinical placements for practical training.

Best Scientists Citing Pramod K. Srivastava

Trending Scientists

Recently Published Articles